Immunogenicity and Safety of a NeuGcGM3 Based Cancer Vaccine: Results From a Controlled Study in Metastatic Breast Cancer Patients.

Human Vaccines
doi 10.4161/hv.6.9.12571
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Immunotherapeutic Cell-Based Vaccine to Combat Metastatic Breast Cancer

2000English

A Case of Metastatic Uterine Cancer From Breast Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2002English

Safety and Immunogenicity of a Novel Staphylococcus Aureus Vaccine: Results From the First Study of the Vaccine Dose Range in Humans

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2010English

TAS-102 Safety in Metastatic Colorectal Cancer: Results From the First Postmarketing Surveillance Study

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

The Results of a Study of Chemotherapy With Bevacizumab, Oxaliplatin and Paclitaxel in Patients With Metastatic Triple Negative Breast Cancer

Malignant tumours
2017English

Posttraumatic Growth in Women After Breast Cancer Surgery – Preliminary Results From a Study of Polish Patients

Health Psychology Report
PsychiatryClinical PsychologyMental Health
2015English

Clinical Outcomes Based on Multigene Profiling in Metastatic Breast Cancer Patients.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Estimated Costs of Her2-Positive Metastatic Breast Cancer for Patients Initiating an Oral Anticancer Treatment: Results From a French Prospective Observational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Eribulin in Pretreated Metastatic Breast Cancer Patients: Results of the TROTTER Trial—a Multicenter Retrospective Study of Eribulin in Real Life

SpringerPlus
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy